Sucampo Pharmaceuticals, Inc. (SCMP) Announces Its New Debt Offering Of Convertible Notes

Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP) has announced the pricing of a $260.0 million aggregate principal amount of 3.25% convertible senior notes, due 2021.

Keep Reading →